Beaumont Financial Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1957394 NEEDHAM, MA

Position in ABBV

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,927,562

+$181,770 QoQ

Shares Held

7,660

-4.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,994

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Beaumont Financial Advisors, LLC holds $40,048,849 across 7 Drug Manufacturers - General names. ABBV ranks #4 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	111,216	$28,245,527
2	LLY	ELI LILLY & Co	4,760	$5,709,287
3	MRK	Merck & Co., Inc.	15,195	$1,952,557
4	ABBV	AbbVie Inc. This page	7,660	$1,927,562
5	AMGN	Amgen Inc	4,130	$1,495,555
6	BMY	Bristol Myers Squibb Co	8,606	$495,877
7	GILD	Gilead Sciences, Inc.	1,761	$222,484

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,927,562	7,660	-4.6%	Shares	Sole	2026-08-04
2026-03-31	$1,745,792	8,027	-2.8%	Shares	Sole	2026-05-05
2025-12-31	$1,887,555	8,261	-25.5%	Shares	Sole	2026-01-16
2025-09-30	$2,566,620	11,085	-0.2%	Shares	Sole	2025-10-23
2025-06-30	$2,062,052	11,109	+0.3%	Shares	Sole	2025-07-16
2025-03-31	$2,320,224	11,074	+3.5%	Shares	Sole	2025-05-12
2024-12-31	$1,901,923	10,703	-3.6%	Shares	Sole	2025-01-17
2024-09-30	$2,193,212	11,106	+0.6%	Shares	Sole	2024-10-09
2024-06-30	$1,893,237	11,038	+0.5%	Shares	Sole	2024-07-24
2024-03-31	$2,000,914	10,988	+0.6%	Shares	Sole	2024-05-10
2023-12-31	$1,692,737	10,923	+1.9%	Shares	Sole	2024-01-31
2023-09-30	$1,598,221	10,722	+6.1%	Shares	Sole	2023-11-01
2023-06-30	$1,361,446	10,105	+2.3%	Shares	Sole	2023-08-02
2023-03-31	$1,574,416	9,879	+1.5%	Shares	Sole	2023-05-08
2022-12-31	$1,572,788	9,732	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.